Skip to main content

Table 1 Patient characteristics

From: Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer

Case Age/sex Site of recurrence Tumor size (mm) Time to recurrence (month) Previous operation Original stage Original Tumor site LN dissection Original pathology Adjuvant CT
1 59/M head of pancreas 30 7 TG T4N1M0 lower D2 intestinal yes
2 65/M omental bursa 50 11 PG T3N1M0 lower D2 intestinal yes
3 62/F omental bursa 50 18 PG T2N2M0 middle D2 intestinal yes
4 83/M porta hepatis 25 32 PG T2N1M0 lower D1 intestinal no
5 45/F tail of pancreas 60 16 TG T4N2M0 middle D2 diffuse yes
6 66/M PALN 25 28 PG T3N2M0 upper D2 intestinal yes
7 49/M PALN 35 17 PG T3N1M0 lower D2 intestinal yes
8 79 M hilum of spleen 28 10 PG T2N2M0 lower D1 intestinal yes
9 67/F omental bursa 25 14 TG T3N1M0 lower D2 diffuse yes
10 72/M omental bursa 45 13 PG T2N1M0 upper D2 intestinal no
11 49/M head of pancreas 25 14 PG T3N1M0 lower D2 intestinal yes
12 42/M porta hepatis 40 16 PG T3N1M0 middle D2 diffuse yes
13 66/M porta hepatis 22 19 PG T3N1M0 lower D2 intestinal yes
14 72/F head of pancreas 38 10 TG T4N1M0 lower D1 diffuse yes
15 63/M PALN 20 26 PG T2N1M0 upper D2 intestinal yes
16 70/M omental bursa 26 18 TG T4N0M0 lower D2 diffuse yes
17 62/F omental bursa 55 24 PG T3N1M0 middle D2 intestinal yes
18 45/F tail of pancreas 43 20 PG T2N2M0 lower D2 intestinal yes
19 55/F PALN 52 16 PG T1N2M0 upper D1 intestinal yes
20 58/M PALN 22 30 PG T3N1M0 lower D2 intestinal yes
21 71/M hilum of spleen 45 9 TG T$N2M0 lower D2 diffuse yes
22 62/F omental bursa 48 24 TG T3N1M0 middle D2 intestinal yes
23 45/M PALN 25 23 PG T2N1M0 lower D2 intestinal yes
24 68/F tail of pancreas 38 32 PG T2N1M0 lower D2 intestinal yes
25 71/M PALN 35 36 PG T2N1M0 upper D2 intestinal no
26 76/M porta hepatis 22 24 PG T4N0M0 upper D1 intestinal yes
27 49/F omental bursa 30 11 TG T3N2M0 middle D2 diffuse yes
28 79/M PALN 20 14 PG T3N1M0 lower D1 intestinal no
  1. PALN:para-aortic lymph node; TG: total gastrectomy; PG: partial gastrectomy; TNM stage: International Union Against Cancer (UICC 2002) TNM system; LN: lymph node; CT: chemotherapy.